A5I7L3 AF NFT

DNA-directed RNA polymerase subunit beta'

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeib5btftldqqyo5rxv6gyyvmojctqcyn466bzsna6ppmueubbbp5uu/metadata.json
IPFS of structure file: 
bafybeid7adswmj3atmo5nqhfgptewotypnbbxofrxcsootw6ezfosbmxvy/AF-A5I7L3-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x40eeFb683B906BDd6284897B2F4EE98a0eAf22bd
First NFT owner address (bech32): 
genesis1grh0k6pmjp4a6c5y39aj7nhf3g827g4awp0s0n
Current NFT ID #388311 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
388311
Accession (UniProt):
A5I7L3
Name::
DNA-directed RNA polymerase subunit beta'
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A5I7L3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A5I7L3|RPOC_CLOBH DNA-directed RNA polymerase subunit beta' OS=Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A) OX=441771 GN=rpoC PE=3 SV=1 MFELNNFDALQIGLASPEKIREWSRGEVKKPETINYRTLKPERDGLFCERIFGPMKDWECHCGKYKRIRYKGIVCDRCGVEVTKAKVRRERMGHIELAAPVSHIWYFKGIPSRMGLILDMSPRALEKVLYFASYVVLDPKETPLLKKQLLNEKEYRESIDKYGDDSFVAAMGAEAVKTLLDEIDLEQSSIELKEELKTSTGQKKIRIIRRLEVVESFRKSGNRPDWMVIDVIPVIPPDLRPMVQLDGGRFATSDLNDLYRRVINRNNRLKKLLDLGAPDIIVRNEKRMLQEAVDALIDNGRRGRPVTGPGNRPLKSLSDMLKGKQGRFRQNLLGKRVDYSGRSVIVVGPELKMYQCGLPKEMALELFKPFVMKKLVQNGLAHNIKSAKRMVERVQPQVWDVLEEVISDHPVLLNRAPTLHRLGIQAFQPVLVEGRAIKLHPLVCTAYNADFDGDQMAVHVPLSVEAQAEARFLMLAAHNILKPSDGKPVSVPTQDMVLGSYYLTMDKDGVKGEGKVFSCPEEVLMAYQCKAVDIHAKIKVRLKKVIDGETIEGIIETTPGKIIFNESIPQDLGYIDRTVPENKLKLEVDFLVSKKTLGGIINRCYMKHGATKTSIMLDKIKAKGYHYSTIGAITISTSDMVVPEAKRELLQNTEKQVEKIQKMYRRGFISEEERYEKVIDLWTKTTEDVANALMASLDSFNPIYMMADSGARGSKSQIKQLAGMRGLMANPSGKIIELPIKASFREGLDVLEYFISTHGARKGNADTALKTADSGYLTRRLVDVSQDVIVRQEDCGTEEGYEVSEIKEGNEVIEPLVERLSGRYPSEDIINPTTGEVIVKRNTYMNEDIAKKVSDAGIKKVKIRSVFTCKSKHGVCARCYGMNMATSQKIHIGEAVGIVAAQSIGEPGTQLTMRTFHTGGVAGADITQGLPRVEELFEARKPKGLAIVSEVSGTVKMEETKKKRTIIVVTDDGEEVSYDIPFGSRIKVKNGDIISAGDEITEGSINPHDILRIKGVDGVKNYLLSEVQKVYRLQGVDINDKHLEVVIRQMTRKIKIEDSGDTELLPGTMIDVFDFEEANREILEKGGEPAVGRIALLGITKAALATDSFLSAASFQETTRVLTDAAIKGKIDPLLGLKENVIIGKLIPAGTGMTRYRSIQINTDDENIEEDSMDSIEV